Enhanced presentation of MHC class Ia, Ib and class II-restricted peptides encapsulated in biodegradable nanoparticles: a promising strategy for tumor immunotherapy

BACKGROUND: Many peptide-based cancer vaccines have been tested in clinical trials with a limited success, mostly due to difficulties associated with peptide stability and delivery, resulting in inefficient antigen presentation. Therefore, the development of suitable and efficient vaccine carrier sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wenxue, Smith, Trevor, Bogin, Vladimir, Zhang, Yu, Ozkan, Cengiz, Ozkan, Mihri, Hayden, Melanie, Schroter, Stephanie, Carrier, Ewa, Messmer, Davorka, Kumar, Vipin, Minev, Boris
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078865/
https://www.ncbi.nlm.nih.gov/pubmed/21450109
http://dx.doi.org/10.1186/1479-5876-9-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078865/
https://www.ncbi.nlm.nih.gov/pubmed/21450109
http://dx.doi.org/10.1186/1479-5876-9-34

Ejemplares similares